140 related articles for article (PubMed ID: 8726009)
21. Postexposure factors influencing the duration of postantibiotic effect: significance of temperature, pH, cations, and oxygen tension.
Fuursted K
Antimicrob Agents Chemother; 1997 Aug; 41(8):1693-6. PubMed ID: 9257743
[TBL] [Abstract][Full Text] [Related]
22. In vitro postantibiotic effects of tomopenem (CS-023) against Staphylococcus aureus and Pseudomonas aeruginosa.
Tomozawa T; Sugihara C; Kakuta M; Sugihara K; Koga T
J Med Microbiol; 2010 Apr; 59(Pt 4):438-441. PubMed ID: 20093378
[TBL] [Abstract][Full Text] [Related]
23. Impact of pharmacokinetics on the postantibiotic effect exhibited by Pseudomonas aeruginosa following tobramycin exposure: application of an in-vitro model.
Zhu ZY; Li RC
J Antimicrob Chemother; 1998 Jul; 42(1):61-5. PubMed ID: 9700529
[TBL] [Abstract][Full Text] [Related]
24. [The effect of clindamycin on intraphagocytic Staphylococcus aureus in leukocytes from patients with chronic osteomyelitis].
Burgaleta C; Velasco GL; Peletier R; Messeguer M; Pernas M
Enferm Infecc Microbiol Clin; 1992 Mar; 10(3):143-7. PubMed ID: 1576187
[TBL] [Abstract][Full Text] [Related]
25. Effects of macrolides on ultrastructure of Staphylococcus aureus during postantibiotic phase.
Watanabe T; Kanno M; Tejima E; Orikasa Y
Drugs Exp Clin Res; 1992; 18(3):81-8. PubMed ID: 1425207
[TBL] [Abstract][Full Text] [Related]
26. Clindamycin treatment of experimental chronic osteomyelitis due to Staphylococcus aureus.
Norden CW; Shinners E; Niederriter K
J Infect Dis; 1986 May; 153(5):956-9. PubMed ID: 3701108
[TBL] [Abstract][Full Text] [Related]
27. Inducible clindamycin and methicillin resistant Staphylococcus aureus in a tertiary care hospital, Kathmandu, Nepal.
Adhikari RP; Shrestha S; Barakoti A; Amatya R
BMC Infect Dis; 2017 Jul; 17(1):483. PubMed ID: 28693489
[TBL] [Abstract][Full Text] [Related]
28. Gepotidacin (GSK2140944)
Flamm RK; Farrell DJ; Rhomberg PR; Scangarella-Oman NE; Sader HS
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483959
[TBL] [Abstract][Full Text] [Related]
29. Synergistic antimicrobial activity of melittin with clindamycin on the expression of encoding exfoliative toxin in Staphylococcus aureus.
Mahmoudi H; Alikhani MY; Imani Fooladi AA
Toxicon; 2020 Aug; 183():11-19. PubMed ID: 32450143
[TBL] [Abstract][Full Text] [Related]
30. Post-antibiotic effect of the new streptogramin RP 59500.
Chin NX; Neu HC
Eur J Clin Microbiol Infect Dis; 1992 Jul; 11(7):642-5. PubMed ID: 1396777
[TBL] [Abstract][Full Text] [Related]
31. Clindamycin bioavailability and pharmacokinetics following oral administration of clindamycin hydrochloride capsules in dogs.
Batzias GC; Delis GA; Athanasiou LV
Vet J; 2005 Nov; 170(3):339-45. PubMed ID: 16266847
[TBL] [Abstract][Full Text] [Related]
32. Telithromycin post-antibiotic and post-antibiotic sub-MIC effects for 10 Gram-positive cocci.
Jacobs MR; Bajaksouzian S; Appelbaum PC
J Antimicrob Chemother; 2003 Nov; 52(5):809-12. PubMed ID: 14519674
[TBL] [Abstract][Full Text] [Related]
33. [Evaluation of the performance of the MicroScan Pos Breakpoint Combo Panel Type 28 for susceptibility testing of Staphylococcus aureus: low-range minimum inhibitory concentration of vancomycin, cefoxitin screening, and inducible clindamycin resistance detection].
Ji M; Lee M; Noh S; Kim MN
Korean J Lab Med; 2010 Dec; 30(6):637-46. PubMed ID: 21157151
[TBL] [Abstract][Full Text] [Related]
34. In vitro killing kinetics and postantibiotic effect of josamycin and other macrolides on several bacteria.
Minguez F; Ramos C; Loscos A; Chiu ML; Prieto J
Chemotherapy; 1993; 39(3):163-8. PubMed ID: 8389685
[TBL] [Abstract][Full Text] [Related]
35. Erythromycin-induced resistance to clindamycin in Staphylococcus aureus.
Marr JK; Lim AT; Yamamoto LG
Hawaii Med J; 2005 Jan; 64(1):6-8. PubMed ID: 15751751
[TBL] [Abstract][Full Text] [Related]
36. Clindamycin resistance among Staphylococcus aureus strains in Israel: implications for empirical treatment of skin and soft tissue infections.
Stein M; Komerska J; Prizade M; Sheinberg B; Tasher D; Somekh E
Int J Infect Dis; 2016 May; 46():18-21. PubMed ID: 26987479
[TBL] [Abstract][Full Text] [Related]
37. Inducible clindamycin resistance in Staphylococcus aureus: a study from North India.
Gupta V; Datta P; Rani H; Chander J
J Postgrad Med; 2009; 55(3):176-9. PubMed ID: 19884741
[TBL] [Abstract][Full Text] [Related]
38. Norfloxacin and ursolic acid: in vitro association and postantibiotic effect against Staphylococcus aureus.
Filocamo A; Bisignano C; D'Arrigo M; Ginestra G; Mandalari G; Galati EM
Lett Appl Microbiol; 2011 Aug; 53(2):193-7. PubMed ID: 21609344
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetic considerations in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis.
Toma MB; Smith KM; Martin CA; Rapp RP
Orthopedics; 2006 Jun; 29(6):497-501. PubMed ID: 16786941
[No Abstract] [Full Text] [Related]
40. Clindamycin suppresses virulence expression in inducible clindamycin-resistant Staphylococcus aureus strains.
Hodille E; Badiou C; Bouveyron C; Bes M; Tristan A; Vandenesch F; Lina G; Dumitrescu O
Ann Clin Microbiol Antimicrob; 2018 Oct; 17(1):38. PubMed ID: 30342546
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
